BDSX.NASDAQBiodesix INC

Form 4: BIODESIX Director Increases Stake After Reverse Split

Sentiment:

Insider Transaction Report


BIODESIX Director and 10% owner Jack W. Schuler acquired additional common stock through trusts following a recent one-for-twenty reverse stock split.

Better than expectedA Director and 10% owner increased their stake in the company, which is often interpreted as a sign of confidence in the company's prospects.The purchases occurred after a significant corporate action (reverse stock split), suggesting a strategic investment decision.

Summary

  • Jack W. Schuler, a Director and 10% owner of BIODESIX INC, reported two purchases of common stock.
  • On September 17, 2025, 15,317 shares were acquired at a weighted average price of $6.0437 per share.
  • On September 18, 2025, an additional 3,056 shares were acquired at a weighted average price of $6.1695 per share.
  • These transactions were made indirectly through the Jack W. Schuler Living Trust, for which Jack W. Schuler is the sole trustee.
  • The reported share numbers reflect adjustments for a one-for-twenty reverse stock split effective September 15, 2025.
  • Following these transactions, the Jack W. Schuler Living Trust beneficially owns 1,238,700 shares, and the Jack W. Schuler 2025 GRAT beneficially owns 750,000 shares, totaling 1,988,700 shares beneficially owned by Jack W. Schuler.

Sentiment

Score: 8

Explanation: Significant insider buying by a director and 10% owner, especially after a reverse stock split, indicates strong confidence in the company's valuation and future prospects.

Positives

  • A Director and 10% owner, Jack W. Schuler, increased his beneficial ownership in BIODESIX INC, signaling confidence in the company's future.
  • The purchases occurred after a one-for-twenty reverse stock split, indicating a potential belief in the stock's value post-split adjustment.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

  • Jack W. Schuler, a Director and 10% owner of BIODESIX INC, acquired common stock through the Jack W. Schuler Living Trust, for which he is the sole trustee.
  • Jack W. Schuler is also the sole trustee of the Jack W. Schuler 2025 GRAT, which beneficially owns 750,000 shares of common stock.

Stakeholder Impact

  • Shareholders: Increased confidence due to insider buying, potentially signaling a positive outlook for the stock valuation.

Key Dates

DateDescription
09/15/2025One-for-twenty reverse stock split effective.
09/17/2025Acquisition of 15,317 shares of Common Stock by Jack W. Schuler Living Trust.
09/18/2025Acquisition of 3,056 shares of Common Stock by Jack W. Schuler Living Trust.
09/19/2025Date of filing signature.

Recommendation

buy

The significant purchases by a Director and 10% owner, Jack W. Schuler, following a reverse stock split, suggest strong insider confidence in BIODESIX INC's future performance and valuation. This insider buying activity often precedes positive stock performance.

Keywords

BIODESIX, BDSX, insider trading, Form 4, stock purchase, director, 10% owner, reverse stock split, Jack W. Schuler

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.